Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

Wednesday’s trading has closed, but IMMU is being traded in the after-hours session. After-Hours quote »
2.17
Delayed Data
As of 3:59pm ET
 +0.05 / +2.36%
Today’s Change
1.69
Today|||52-Week Range
5.48
-54.79%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close2.12
Today’s open2.15
Day’s range2.07 - 2.21
Volume540,407
Average volume (3 months)1,637,733
Market cap$200.6M
Dividend yield--
Data as of 3:59pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)-21.43%
Earnings growth (this year)+42.16%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-37.48%
P/E ratioNM
Price/Sales67.02
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CUTRCutera Inc+0.31+2.11%
EARSAuris Medical Holdin...-0.30-6.52%
AXGNAxoGen Inc-0.03-0.64%
TEARTearLab Corp+0.05+1.95%
Data as of 3:59pm ET, 09/02/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$5.7M
Annual profit (last year)-$48.0M
Net profit margin-849.13%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts

Partner Offers